I. GULYAKIN, “FEATURES OF THE DEVELOPMENT OF A LYOPHILIZED INJECTABLE DOSAGE FORM OF THE ORIGINAL ANTICANCER DRUG LCS-1208”, Int J App Pharm, vol. 13, no. 4, pp. 102–105, Jul. 2021.